Gruber, T.; Robatel, S.; Kremenovic, M.; Bäriswyl, L.; Gertsch, J.; Schenk, M.
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers 2021, 13, 1934.
https://doi.org/10.3390/cancers13081934
AMA Style
Gruber T, Robatel S, Kremenovic M, Bäriswyl L, Gertsch J, Schenk M.
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers. 2021; 13(8):1934.
https://doi.org/10.3390/cancers13081934
Chicago/Turabian Style
Gruber, Thomas, Steve Robatel, Mirela Kremenovic, Lukas Bäriswyl, Jürg Gertsch, and Mirjam Schenk.
2021. "Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma" Cancers 13, no. 8: 1934.
https://doi.org/10.3390/cancers13081934
APA Style
Gruber, T., Robatel, S., Kremenovic, M., Bäriswyl, L., Gertsch, J., & Schenk, M.
(2021). Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers, 13(8), 1934.
https://doi.org/10.3390/cancers13081934